Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma ...
Matthew Herper covers medical innovation — both its promise and its perils. Pfizer said Thursday its drug Ibrance showed efficacy in a group of breast cancer patients who do not currently have access ...
On Thursday, Pfizer Inc. (NYSE:PFE) and Alliance Foundation Trials, LLC (AFT) announced results from the Phase 3 PATINA trial. The trial demonstrated that the addition of IBRANCE (palbociclib) to ...
It’s unusual to have the FDA chase down a pharma company and ask them apply for a new drug indication. But Pfizer went through just that and has now quietly revealed a label expansion for blockbuster ...
The second round of Medicare negotiations are here, with the Centers for Medicare and Medicaid (CMS) unveiling the new maximum fair prices for the 15 drugs Tuesday. The list of drugs includes obesity ...
Despite two life extension wins, Novartis still finds it tough to convince doctors to use its breast cancer drug Kisqali over Pfizer’s first-to-market Ibrance. Now, with a third survival victory under ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. IBRANCE contains the active ingredient palbociclib. IBRANCE is used to ...
Rachel Cohrs Zhang reported on the intersection of health policy and business in Washington. She covered Capitol Hill, lobbying, and federal agencies. Her primary areas of focus were the ...
Semaglutide, the popular drug sold by Novo Nordisk as Ozempic for diabetes and Wegovy for weight loss, is among a group of widely used medicines selected by the U.S. government for the next round of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results